期刊文献+

依折麦布的酶法合成 被引量:1

On Enzymatic Synthesis of Ezetimibe
下载PDF
导出
摘要 以价廉易得的氟苯和戊二酸为原料,经傅-克反应、酰胺化、酮的还原、偶联和环合等数步反应合成依折麦布,总收率为7.5%.其中,用KRED238全细胞酮还原酶直接还原化合物5的羰基获得了具有S构型的羟基化合物中间体6,该步反应的收率为95%,(S)-羟基de值95.68%,还原反应的立体选择性高.该结果证实了生物催化技术应用于依折麦布合成中的可行性,为依折麦布绿色不对称合成工艺的发展提供了新的思路. From the cheap raw materials fluorobenzene and pentanedioic acid,ezetimibe has been synthesized by six steps reaction such as Friedel-Crafts reaction,acylation reaction,reduction reaction,coupling reaction and cyclization etc.The total yield of ezetimibe is 7.5%.The key step has been performed by KRED238 ketoreductase from the compound 5and obtained a S configuration intermediate compound 6in a yield of 95%,the dextrose equivalent value is 95.68%.The reduction reaction has been carried out with a high stereoselectivity.The results demonstrate that the biocatalytic technology can be used for the synthesis of ezetimibe.It provides a new way for the development of green asymmetric synthesis of ezetimibe.
出处 《西南师范大学学报(自然科学版)》 CAS 北大核心 2015年第10期173-176,共4页 Journal of Southwest China Normal University(Natural Science Edition)
关键词 依折麦布 酮还原酶 合成 ezetimibe ketoreductase synthesis
  • 相关文献

参考文献14

二级参考文献82

  • 1金晓华.β-内酰胺类抗生素在医药市场的发展前景[J].商场现代化,2006(06X):107-107. 被引量:1
  • 2PEARSON TA, DENKE MA, MCBRIDE PE, et al. A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial[ J]. Mayo Clin Proc, 2005,80 (5) :587 - 595.
  • 3KASHANI A, SALLAM T, RHEEMREDDY S, et al. Review of side-effect profile of combination ezetimibe and statin therapy in randomized clinical trials [J].Am J Cardiol, 2008,101 ( 11 ) : 1606 - 1613.
  • 4ARA R, TUMUR I, PANDOR A, et al. Ezetimibe for the treatment of hypercholesterolaemia:a systematic review and economic evaluation [ J ]. Health Technol Assess, 2008,12 ( 21 ) : 1 - 212.
  • 5CHENOT F, MONTANT PF, MARCOVITCH O, et al. Co-administration of ezetimibe and simvastatin in acute myocardiai infarction [ J ]. Eur J Clin Invest, 2007,37 ( 5 ) : 357 - 363.
  • 6CONSTANCE C, WESTPHAL S, CHUNG N, et al. Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus [J]. Diabetes Obes Metab , 2007,9(4) :575 -584.
  • 7GAUDIANI LM, LEWIN A, MENEGHINI L, et al. Efficacy and safety of ezetimibe co-administered with simvastatin in thiazolidin-edione-treated type 2 diabetic patients [J]. Diabetes Obes Metab, 2005,7(1) :88 -97.
  • 8HAJER GR, DALLINGA-THIE GM, VAN VARK-VAN DER ZEE LC, et al. The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients [ J ]. Atherosclerosis, 2009, 202 ( 1 ) : 216 -224.
  • 9KONSTANDIN MH, BLESSING E, DOESCH A, et al. Ezetimibe effectively lowers LDL-cholesterol in cardiac allograft recipients on stable statin therapy [J]. Clia Transplant, 2008,22 (5) : 639 - 644.
  • 10KOHNLE M, PIETRUCK F, KRIBBEN A, et al. Ezetimibe for the treatment of uncontrolled hypcrcholesterolemia in patients with high-dose statin therapy after renal transplantation[J]. Am J Transplant, 2006,6 (1) : 205 - 208.

共引文献48

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部